Ikarian Capital’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-150,900
| Closed | -$231K | – | 106 |
|
|
2025
Q1 | $231K | Sell |
150,900
-199,100
| -57% | -$305K | 0.03% | 93 |
|
|
2024
Q4 | $868K | Buy |
+350,000
| New | +$868K | 0.12% | 71 |
|
|
2024
Q1 | – | Sell |
-19,482
| Closed | -$20.5K | – | 84 |
|
|
2023
Q4 | $20.5K | Buy |
+19,482
| New | +$20.5K | ﹤0.01% | 76 |
|
|
2023
Q3 | – | Sell |
-200,163
| Closed | -$2.08M | – | 83 |
|
|
2023
Q2 | $2.08M | Sell |
200,163
-100,000
| -33% | -$1.04M | 0.33% | 31 |
|
|
2023
Q1 | $2.43M | Buy |
+300,163
| New | +$2.43M | 0.55% | 33 |
|
|
2022
Q2 | – | Sell |
-12,124
| Closed | -$208K | – | 99 |
|
|
2022
Q1 | $208K | Buy |
12,124
+1,339
| +12% | +$23K | 0.03% | 126 |
|
|
2021
Q4 | $156K | Sell |
10,785
-31,927
| -75% | -$462K | 0.02% | 129 |
|
|
2021
Q3 | $770K | Sell |
42,712
-47,076
| -52% | -$849K | 0.05% | 104 |
|
|
2021
Q2 | $1.58M | Sell |
89,788
-98,412
| -52% | -$1.73M | 0.13% | 96 |
|
|
2021
Q1 | $4.74M | Sell |
188,200
-111,800
| -37% | -$2.82M | 0.16% | 44 |
|
|
2020
Q4 | $1.94M | Buy |
+300,000
| New | +$1.94M | 0.09% | 75 |
|